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ABSTRACT 
OBJECTIVES: To provide the best possible evidence base for guiding driving decisions in 
Parkinson’s disease (PD), we performed a meta-analysis comparing PD patients to healthy controls 
(HCs) on naturalistic, on-the-road and simulator driving outcomes. METHODS: Seven major 
databases were systematically searched (to 01/2018) for studies comparing PD patients with HCs 
on overall driving performance, with data analysed using random-effects meta-analysis. RESULTS: 
Fifty studies comprising 5,410 participants (PD=1,955, HC=3,455) met eligibility criteria. Analysis 
found the odds of on-the-road test failure were 6.16 (95% CI,
 
3.79-10.03) times higher and the 
odds of simulator crashes 2.63 (95% CI,1.64-4.22) times higher for people with PD, with poorer 
overall driving ratings also observed (SMDs=0.50 to 0.67). However, self-reported real-life crash 
involvement did not differ between people with PD and HCs (Odds Ratio=0.84, 95% CI, 0.57-1.23, 
p=.38). Findings remained unchanged after accounting for any differences in age, sex and driving 
exposure, and no moderating influence of disease severity was found. CONCLUSIONS: Our 
findings provide persuasive evidence for substantive driving impairment in PD, but offer little 
support for mandated PD-specific relicensure based on self-reported crash data alone, and 
highlight the need for objective measures of crash involvement. 
 
Keywords: Parkinson’s disease; neurodegeneration; driving; fitness to drive; meta-analysis; 
crashes. 
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1 INTRODUCTION 
Parkinson’s disease (PD) symptoms can include motor instability, increased response time, 
attentional deficits, visual impairment, daytime sleepiness and medication-exacerbated sleep 
attacks.
4
 As all of these factors may compromise capacity to drive, this has caused concerns over 
the driving safety of people with PD and led to recent policy debate over the need for mandatory 
based reevaluation of fitness to drive in those with degenerative diseases.
1
 
 
As cessation of driving can compromise independence and lead to isolation, such decisions should 
be informed by the best possible evidence base. Unfortunately, research findings are somewhat 
inconsistent, likely due to considerable variation in study methodology, and there is currently no 
clear overall picture of driving safety risk in PD, or whether this risk is influenced by disease stage 
or medication use. 
 
While narrative reviews
5,11
 have been helpful in summarizing research evidence on driving 
impairment, there is a pressing need for a quantitative synthesis of all available empirical data 
that accounts for study heterogeneity, to provide the best possible evidence for guiding driving 
decisions in PD. The current study is the first meta-analysis to compare individuals with PD and 
healthy controls on driving performance measures from on-the-road, driving simulator and real-
life crash studies and aims to establish: (1) precise estimates of the magnitude of any driving 
impairment; (2) the influence of severity stage and medication dosage on impairment; and (3) 
whether PD is linked to both poorer performance on driving assessments and an inflated real-life 
crash risk.   
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2 METHODS 
This systematic review and meta-analysis was conducted in accordance with PRISMA guidelines,
14
 
and followed an a priori but unpublished protocol available upon request. 
 
2.1 Eligibility Criteria 
Inclusion criteria were the use of: (1) a group with a diagnosis of primary (idiopathic) Parkinson’s 
disease (PD); (2) a neurologically healthy control (HC) group, (3) at least one quantitative measure 
of driving performance from real-world driving data, on-the-road tests or driving simulator 
assessments. 
 
Three types of driving assessment were included to provide a comprehensive evaluation of driving 
performance. Real-world, naturalistic assessment typically provides crash data and thus a direct 
measure of safety risk. On-the-road assessments do not offer direct measures of crash risk, but do 
provide an accepted standard measure of fitness to drive, and expose both groups to the same 
driving challenges thus circumventing any effect of compensatory strategies (e.g. avoiding night 
driving) that can mask genuine driving deficits. High fidelity simulators are less naturalistic, but 
can use a range of driving conditions and assess driving response to situations with high crash 
potential.  
 
Studies were excluded if outcomes were measures of driving strategy
13
 only (e.g. avoiding rush 
hour), as the focus of this study is the involuntary degradation of functional driving ability in PD 
(rather than voluntary driving behaviours). We also excluded studies assessing performance 
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outside of a driving context (e.g. Stroop response time), given the inconsistent link between such 
neuropsychological assessments and actual road performance.
2
 
 
2.2 Driving outcomes 
Primary outcomes were (a) crashes (e.g. crash involvement (yes/no) or number of crashes), and 
(b) overall driving competence (e.g. test failure or overall performance ratings).  
 
We examined only aggregate or overall driving competence outcomes, as separate analysis of all 
individual driving components that typically comprise overall outcome scores (e.g. lane deviation, 
road excursions) would produce excessive Type-I errors and multiple analyses varying in their 
sample sizes and methodological characteristics. We excluded (a) absolute speed as its 
relationship with driving competence is complex and dependent upon driving context
23
 and (b) 
use of gears, route recall or pedal (e.g. brake) pressure, as these were not considered to be direct 
measures of driving competence. 
 
2.3 Information Sources 
PubMed, Embase, Transport Research International Documentation, CENTRAL, CINAHL Plus with 
Full Text, PsycINFO and Web of Science databases were searched from database inception until 
25
th
 January, 2018.  
2.4 Search terms 
Searches of database subject headings (where provided) and free text words of all fields were 
conducted to identify the largest possible pool of potentially eligible studies. PubMed search 
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terms were as follows, with equivalent strings constructed for other databases: (“automobile 
driving” [mh] OR driving[tw] or automobile[tw] or simulator[tw] or simulate[tw] or road-test[tw]) 
AND (“Parkinson disease”[mh] OR Parkinson*[tw]). 
 
No language restrictions were imposed. Searches were filtered with the Cochrane sensitivity-
maximising human filter. The search strategy was augmented through hand searching of relevant 
reviews and included articles. 
2.5 Study selection 
After removal of duplicates, two independent reviewers (CM, DP) screened titles/abstracts (stage 
1), followed by full-text review of any resultant potentially eligible articles (stage 2). If multiple 
articles presented the same outcome data, only one article was retained (that with the clearest 
reporting or largest sample size), unless other articles also reported additional unique outcomes 
(in which case only unique outcomes were used). Ten corresponding authors of eligible articles 
were contacted across an eight-week period to clarify procedures or request additional data, with 
a single follow-up email sent in the event of non-response. Six authors (see acknowledgements 
section) replied and provided query resolutions. Any disagreements at any stage of the selection 
process were resolved through discussion with a third reviewer (TT) to reach a final list of retained 
articles.  
2.6 Quality of evidence 
Two reviewers (CM, DP) independently rated the quality of supporting evidence on an 18-item 
validity scale (Appendix e-1) based on Cochrane criteria and PRISMA recommendations and 
adapted from our previous work
19
 for the current topic. Criteria were scored as unmet if their 
endorsement could not be explicitly demonstrated (i.e. criteria were unmet or unreported). 
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2.7 Standard protocol approvals, registrations, and patient consents 
No additional ethics approval was required for this meta-analysis.  
 
2.8 Data Extraction 
Extraction and coding of study data was performed by one reviewer (CM) on a standardized form 
19
 with 100% of extracted data checked for accuracy by one reviewer (TT). The following data were 
extracted: (1) sociodemographic variables; (2) For PD: mean disease duration (years), symptom 
severity, functional state (ON/OFF) during driving/disease assessment, diagnostic criteria, 
cognitive impairment, usual treatment; (3) lifetime driving experience (e.g. years licence held) and 
current driving exposure (e.g. miles driven per week); (4) assessment model (real-life, on-the-
road, driving simulator) and (5) outcomes. Where study data allowed computation of multiple 
effect sizes (e.g. across repeated trials), all such data were extracted.  
 
Several extraction decisions were made: (1) where experimental manipulations were used during 
driving assessment (k=2), baseline data only was extracted; (2) for one research group reporting 
total and individual driving scores, we extracted the latter due to ambiguity in the former; (3) for 
one prospective study
25
 that reported raw crash data and crash data adjusted for different group 
follow-up periods and other potential confounds, we included adjusted statistics only; (4) for one 
study reporting test outcome as safe/unsafe, we recoded this as pass/fail for consistency; (5) a 
few studies reported median outcomes which we used as an approximation of the mean. The 
impact of decisions 4-5 was examined in sensitivity analysis. 
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2.9 Effect size 
For continuous outcomes, the standardized mean difference (SMD) for PD vs. HCs was computed 
using Hedges' g formula, where .20, .50 and .80 can be roughly translated as small, medium and 
large effects.
3
 For categorical outcomes (e.g. crash history yes/no), odds ratios (OR) were 
computed (log OR were used in the meta-analysis and subsequently converted back to OR). 
 
Effect sizes were coded so that positive values (for both SMD and log OR) indicated driving 
impairment in PD (e.g. more driving errors, higher crash rate). 
2.10 Meta-analysis 
Group differences in driving outcomes were estimated using a random-effects model given 
anticipated heterogeneity in effect size. Robust variance estimation (RVE)
20
 was used to model 
dependency amongst multiple effect sizes from within a study (when total and subscore effect 
sizes were reported we included only the former). As the same patient groups were used across 
several studies (identified by contacting authors and examining article text/data), we also reran 
analysis including patient group as a second-order hierarchical variable to account for sample 
dependency.  
 
Meta-analysis was performed on data collapsed across real-life, on-the-road and simulator 
models. Assessment model was also added as a dummy-coded moderator, and if significant, 
separate meta-analyses were performed for each model. Analyses were not performed if adjusted 
df<4 (reflecting insufficient independent studies) as such model estimates are unreliable.
20
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2.11 Meta-regression 
If moderate or greater inconsistency (I
2
>50%
10
) in effect size emerged, meta-regression analyses 
were performed to identify potential sources of effect size variation. 
 
The primary moderator was disease severity (symptom severity/disease duration), as increased 
neurodegeneration causes greater impairment. Secondary moderators consisted of medication 
dosage (L-dopa equivalent), study sex ratio, age, and lifetime driving experience.  
 
If PD and HC groups differed on potential confounds of driving experience, age, and sex, which 
could explain group differences in driving outcomes, we reran analyses entering standardized 
difference scores on these variables as covariates. For real-life crash data, where miles driven 
cannot be experimentally fixed to be equivalent across groups, we included current driving 
exposure (e.g. mileage) differences over the assessed crash period as a covariate. 
2.12 Publication bias 
Funnel plots of mean study effect sizes against standard errors were examined for Indicators of 
possible publication bias, with any asymmetry due to a lack of small studies with small effects 
tested statistically.
8,16
  
2.13 Analysis software 
All analyses were performed using the metafor
28
 and robumeta
9
 packages in R. 
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3 RESULTS 
3.1 Study selection and data characteristics 
3.1.1 Study inclusion  
3,962 unique hits were identified through database searches, with initial screening of 
titles/abstracts identifying 226 potentially eligible articles, further reduced to 54 eligible articles 
following full text review (Figure 1). Of these 54 articles, 50 provided sufficient quantitative data 
for meta-analysis consisting of a total N=5,410 (PD n=1,955, HC n=3,455). The 50 articles 
represented 43 journal publications, 4 conference abstracts, 2 PhD theses and 1 transport report. 
Detailed individual study characteristics are presented in Table e-1 and summarized below. 
3.1.2 Participant characteristics 
37 unique participant samples were identified as being used across the 50 studies (often with 
different driving models/outcomes) with an aggregate N=4,149 (n=1,576 PDs, n=2,573 HCs). Mean 
age (reported for k=36 of 37 samples) was similar for PD (M=66.6 yrs, SD=4.7, range=54-75) and 
HCs (M=65.6 yrs, SD=6.8, range=48-77), although the mean proportion of males (k=31) was higher 
for PD (M=74%, SD=17.6, range=12-100) compared to HCs (M=62%, SD=18.1, range=14-100). 
 
Where lifetime driving experience had been reported (k=24), PDs and HCs were similar in mean 
years of driving experience (k=15; PD M=44.2 yrs, HC M=42.9 yrs), and when other classifications 
(k=9) were used, such as the proportion of participants with >10 years’ driving experience. Current 
driving exposure (k=24) was assessed in a variety of metrics with most studies reporting similar 
values for both groups, e.g. number of days driven per week (k=8; PD M=5.2, HC M=5.5). 
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Samples were recruited from the following locations: USA (k=15), Australia (k=7), Greece (k=3), 
Canada (k=2), France (k=2), Germany (k=2), Belgium (k=1), Denmark (k=1), Finland (k=1), 
Netherlands (k=1), Thailand (k=1) and UK (k=1).  
3.1.3 Parkinson’s disease severity and medication 
Mean disease duration (reported for k=22 of 37 samples) was 6.7 yrs (SD=1.6, range=3.5-10.9) 
with symptom severity assessed during the ON state with the Hoehn-Yahr (k=24; M=2.1, SD=0.4, 
range=1.0-4.0) and/or the UPDRS-III (k=20; M=20.9, SD=5.6, range=11.7-30.1) scales. PD diagnosis 
was confirmed with clinician assessment (k=13) or no diagnostic detail was provided (k=24). All 
studies reported regular use of antiparkinson medication by varying sample proportions, with 
k=21 studies providing exact figures (M=96%, SD=9.0).  
 
 
A minimum level of cognitive functioning in PD for study inclusion was specified by 14 studies, 
with MMSE>=24 being the most common criterion. The mean MMSE score (k=21) was 28.2. 
Driving assessments were administered during ON states (k=22), with 15 studies not reporting 
ON/OFF state. 
 
3.2 Assessment outcomes 
3.2.1 Real-life driving data 
15 studies provided naturalistic driving data, with 13 providing self-reported crash statistics for 
2,143 (PD n=873, HC n=1,270) participants, and 2 studies providing speed and response times 
using in-car monitoring technology. Crash statistics were (a) the proportion of each group involved 
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in a crash (k=8), and (b) number of crashes (k=5) experienced over a mean period of 3.0 years 
(SD=2.5, range=1-10 years). Crashes were typically treated as driving events causing injury or 
damage to the vehicle. Most assessments consisted of a generic self-report statement (e.g. “how 
many accidents have you been involved in over the past X years?)", with one study corroborating 
self-report with department of transport records.
25
  
3.2.2 On-the-road driving tests 
On-the-road tests were used in k=17 studies, comprised of N=2,079 (PD=724, HC=1,355) 
participants. Tests were generally based on standard certified driving tests and conducted and 
scored in a fairly uniform manner across studies using established, standardized protocols, e.g. 
Iowa Department of Transportation Driving Test Scoring Standards, 2005.
27
 Scoring was carried 
out by a professional driving instructor, k=11, driving rehabilitation specialist, k=8, or trained 
experimenter, k=2 (4 studies used 2 types of assessor). Performance was evaluated during 
assessment (k=12), by post-assessment video review (k=4) or both (k=1). Driving tests were mostly 
of 45-60 minutes duration and performed in an instrumented vehicle in off-peak, daylight hours in 
good weather using a mixture of residential, suburban, urban and highway roads.  
 
Main driving outcomes were (a) test pass/failure (k=8), and/or (b) overall performance score 
(k=15)
a
 
 
typically computed by summing scores on a broad range of individual driving elements 
(e.g. lane deviation, speed control, maneuvers). 
                                                       
 
a
 Three studies
22,23,26
 of 18 originally identified were excluded from analysis of overall test performance, as they 
reported performance subscale scores used to compute overall scores in another included study
24
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3.2.3 Driving simulator assessments 
Twenty-five studies with a total N=1,420 (PD=628, HC=792) assessed driving performance using a 
variety of simulators with real car or simulated cockpits. Sessions typically lasted 5-20 mins (k=12; 
M=11 mins), with multiple sessions sometimes used. Every day driving situations were commonly 
reproduced using different road and traffic conditions involving simple to hazardous driving (e.g. 
cars turning out of side streets). Performance was scored by a driving instructor (e.g. traffic sign 
compliance) or automatically by the simulator (e.g. lane deviation).  
 
Outcomes included (a) crash rate/number of crashes (k=8), usually collisions with pedestrians, 
cars and objects in challenging driving scenarios, and/or (b) performance scores (k=22). 
Performance aspects commonly assessed included speed regulation, lane deviation, reaction time 
(e.g. to red lights), stop sign errors etc. Most (k=14) of the 22 test performance studies assessed 
performance on a relatively broad range of key components, while a few studies (k=8) were 
primarily restricted to a specific, circumscribed outcome, usually reaction time (see Table e-1). 
 
Participant characteristics were similar across real-life, on-the-road and simulator studies 
(sections 3.1.2 and 3.1.3), with the possible exception of PD severity, with UPDRS-III scores 8 
points higher for the on-road sample (M=24.6) compared to the simulator sample (M=16.4). 
3.3 Quality of supporting evidence 
Study validity ratings (Appendix e-1) largely appeared to support sound methodological practices, 
with driving assessed using well-established assessment protocols (96% of studies) and clearly 
defined performance measures (92%). Most studies reported similar group age (86%) and driving 
experience (64%). However, male/female ratio was similar for only 46% of included studies, and 
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thus we examined sex as a possible confounder (section 3.8). Most studies used performance 
measures adjudged to be sufficiently broad to reflect overall competence (74%), but with Table e-
1 showing that some simulator studies used highly specific, circumscribed measures (e.g. reaction 
time to red lights). The potential influence of these studies was accordingly examined in sensitivity 
analysis (section 3.9). Finally, limited information was provided for selection of controls (42%) and 
many studies recruited PD participants from movement disorder clinics, and thus generalizability 
is difficult to ascertain. With respect to PD, movement clinics attract both complex referrals from 
neurologists and relatively non-complex patients from the local community, and thus there 
appears to be no obvious reason why study patients would be unrepresentative of the wider PD 
community. 
3.4 Rater agreement 
Inter-rater agreement for final study selection was 97%, with 86% overall agreement on study 
validity items. All disagreements were resolved following discussion with a third reviewer.  
3.5 Meta-analysis 
3.5.1 All outcome data 
Meta-analysis of all outcome data (k=50) indicated moderate
3
 overall driving impairment in PD 
(Figure 2), SMD=0.48, CI
95
[0.35, 0.62], p<.001. However, a moderating effect of assessment type 
revealed greater impairment for on-the-road (ΔSMD=0.87, p<.001) and simulator (ΔSMD=0.56, 
p=.007) assessments compared to real-life driving and thus meta-analysis was conducted for each 
assessment method separately.  
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3.5.2 Real life data 
Eight studies reporting crash rates (PD M=18.5%, HC M=21.0%) were combined with 5 studies 
reporting mean crashes. Meta-analysis of the 13 studies (N=2,143) revealed slightly lower odds of 
crash involvement for those with PD compared to HCs (Figure 3), but this did not reach 
significance, OR=0.84, CI
95
[0.57, 1.23], p=.38. High inconsistency in the magnitude of these effects 
was observed (I
2
=71% τ
2
=0.40). 
3.5.3 On-the-road driving tests 
Driving test failure rates (k=8; N=821) and test performance scores (k=15; N=1,865) were analyzed 
separately, as test failure rate in particular represents an easily interpretable and meaningful 
index of driving competence. 
 
Analysis revealed the odds of test failure were just over 6 times greater for PD patients (Figure 4), 
OR=6.16, CI
95
[3.79, 10.03], p<.001, with a mean failure rate 46.5% in PD participants and 12.2% in 
HCs. Low heterogeneity was observed (I
2
=24% τ
2
=0.11), with all studies finding higher failure rates 
in PD. Analysis of test performance scores (Figure 5) also found poorer performance in PD 
(SMD=0.67, CI
95
[0.53, 0.80], p < .001), suggesting moderate to high impairment.
3
 All studies 
indicated greater driving impairment in PD, but with variation in the magnitude of impairment 
(I
2
=62% τ
2
=0.07). 
3.5.4 Driving simulators  
Crash data (k=8; N=598) and overall simulator performance scores (k=22; N=1,318) were analyzed 
separately, so that comparisons of crash rates across real-life (section 3.2.1) and simulator models 
can be made.  
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A greater likelihood of simulator crashes (OR=2.63, CI
95
[1.64, 4.22], p=.008) and poorer overall 
driving performance (SMD=0.50, CI
95
[0.33, 0.68], p<.001) was found in PD. The majority of studies 
found poorer performance in PD for crashes (k=8/8) and overall performance (k=19/22), although 
moderate-high variation in the magnitude of this impairment was found (I
2
=60-71% τ
2
=0.20-0.41). 
 
3.6 Publication bias 
Neither funnel plots or statistical tests (p=.27-.99) indicated effect size asymmetry for any 
outcomes, suggesting little detectable evidence of publication bias. 
 
3.7 Meta-regression 
As primary moderator data were only reported by around half of the included studies, meta-
regression was performed for each moderator on the whole dataset (pooled across assessment 
models) to maximize power, with assessment model included as a covariate to control for its 
impact on effect size. SMD (transformed and untransformed) was used as the effect size, as this 
was the predominant statistic reported. 
  
Meta-regression found group differences in driving performance to be unaffected by primary 
moderators of disease duration (k=27; p=.29) and symptom severity (H&Y: k=29; p=.36, UPDRS-III: 
k=24, p=.21), or secondary moderators of age (k=44; p=.39), sex (k=38; p=.38), L-dopa equivalent 
dosage (k=20; p=.14) and years of driving experience (k=16; p=.31). 
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3.8 Confounders 
To control for the higher proportion of males in the PD samples, all analyses were rerun entering 
group differences in male/female proportion as a covariate, but revealed little change in effect 
size (max change: SMD=0.01, OR=0.37). For real-life crash data, we were not able to enter driving 
exposure (section 2.11) over the assessed crash period as a covariate due to limited studies and 
the variety of metrics used (e.g. mileage, trip frequency). Instead, we reran meta-analysis of real-
life crash data (section 3.5.2) including 6 studies (N=943) from the original 13 that reported driving 
exposure in PD as matching or exceeding that of HCs. An identical effect size of OR=0.84, was 
found, demonstrating that lack of differences in self-reported crash rate was unlikely to be 
attributable to reduced driving exposure in PD. 
3.9 Sensitivity analysis 
Recomputing meta-analysis estimates after omitting studies where (a) extraction decisions were 
made (section 2.8), (b) highly circumscribed simulator outcomes (section 3.2.3) were used, and (c) 
SMDs were transformed to ORs and vice-versa (section 3.5.1-3.5.2), resulted in no substantive 
changes in effect size (max change: SMD=.05, OR=0.13). Finally, including patient group as a 
second-order hierarchical variable (section 2.10) resulted in negligible effect size changes, with 
the possible exception of overall performance scores in simulator studies which saw a reduction 
from SMD=.50 to SMD=.30. 
3.9.1 Missing studies 
Four driving simulator studies of varying sample sizes (N=9-53), described in conference abstracts 
by the same author (51-54 in References e-1), were excluded due to insufficient outcome data, 
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but reported results broadly consistent with analyzed data suggesting little evidence of bias from 
their omission. 
 
4 DISCUSSION 
Meta-analysis of 50 studies totalling 5,410 participants provided clear evidence of driving 
impairment in on-the-road (OTR) and driving simulator assessments, but found no evidence of 
increased risk of real-life crash involvement as assessed by self-report. More specifically: (1) In 
OTR tests, the odds of driving test failure were over 6 times higher for PD compared to HCs and 
overall test performance scores indicated moderate to strong impairment (SMD=.67); (2) in 
driving simulator assessments, the odds of crash involvement were over 2.5 times higher in PD 
and overall driving performance scores indicated moderate impairment (SMD=.50); (3) while 
considerable heterogeneity in the magnitude of performance degradation was generally 
observed, direction of effects in OTR and simulator assessments consistently indicated poorer 
performance; (4) no evidence was found that the degree of driving impairment was moderated by 
disease severity, disease duration or medication dosage.  
 
 
Meta-analysis of OTR and simulator data provided convincing evidence of impaired driving 
competency in PD, which could not be attributed to group differences in age or sex. As OTR 
assessments were largely based on established, standardized driving tests used to determine 
licensure and fitness to drive, these results suggest that key skills required for typical every day 
driving challenges are compromised in PD. While simulator assessments may be less 
representative of real-life driving, especially when a single, molecular driving assessment is used 
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(e.g. reaction time to a red light), a consistent pattern of impairment to OTR assessments in 
independent studies was nevertheless observed. This would seem to suggest that, when 
confronted with equivalent driving challenges in real-life, those with PD are likely to perform more 
poorly. Furthermore, driving tests were conducted during optimal conditions (e.g. daylight, good 
weather, optimal medication states), suggesting further performance degradation is likely during 
more difficult conditions when already compromised cognitive, motor and perceptual capacities 
are further challenged.
21
 It is also noteworthy that average Hoehn-Yahr severity stage ranged 
from 1-3 suggesting substantive driving impairment occurs even at the early mild to moderate 
disability levels, when the patient is usually considered to be fully independent in all activities of 
daily living. 
 
However, despite strong evidence of impaired ability, PD was not associated with inflated real-life 
crash risk, based on self-report data from over 2,100 participants. This finding could not be 
attributed simply to reduced driving exposure in PD (e.g. fewer trips or miles covered). One 
possible explanation for the lack of increased crash risk is that people with PD self-regulate their 
driving behaviour in a number of ways. They may use compensatory strategies (e.g. driving more 
slowly, avoiding risky manoeuvres such as turning across traffic flow, using familiar roads, etc.) 
that minimise challenges to their impairments.
7,25
 Additionally, evidence suggests that PD drivers 
with the most severe driving deficits, who are likely to be those with the highest crash 
vulnerability, may simply elect to discontinue driving altogether.
25,27
 A second possibility is that 
the driving deficits observed in PD simply do not contribute substantially to crash risk, with 
established factors such as distracted driving (e.g. cell phone use), speeding, alcohol, driving 
attitude etc. being the primary risk factors for crashes. 
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Given that PD is a progressive disease, the lack of relationship between driving impairment and 
disease duration or severity based on 32 studies is somewhat surprising. This finding suggests that 
driving impairment may occur relatively early on in the disease state with little evidence of further 
deterioration. Nevertheless, several caveats should be applied to this interpretation. First, patient 
samples were generally restricted to those with a Hoehn-Yahr stage of 1-3, and it may be that 
substantial deterioration is seen only at stage 4 (severely disabling), when many PD patients may 
elect to discontinue driving. Second, disease severity measures used, typically Hoehn-Yahr staging 
and UPDRS-III, were based on motor dysfunction. However, it is well recognized that severity of 
non-motor symptoms such as cognitive and visual dysfunction in PD are key predictors for poor 
driving performance.
25,27
 Finally, standardized road tests may fail to detect motor-based 
impairment in driving as they do not include hazardous circumstances that require immediate 
motor response. Nevertheless, real-life and simulator driving do incorporate such hazards, and so 
any existing relationship might still be expected to emerge in these data.
21
 Collectively, there 
appears to be no persuasive evidence that driving progressively degrades with increasing severity 
in motor dysfunction up to Hoehn-Yahr stage 3, but it would be unwise to dismiss this possibility, 
or a role of non-motor symptoms, without further primary studies. 
 
 
There is no persuasive evidence that drivers with PD show an increased real-life crash risk based 
on currently available self-report data. While the reliability of such data is uncertain, they do little 
to advance arguments for immediate legislative change in relicensing or current clinician 
recommendations for those with PD, pending availability of more objective measures. People with 
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PD often self-regulate their driving to limit safety risk,
5,25
 and the most effective reassessment is 
likely to be that performed on an individual case-by-case basis rather than driven by diagnosis.
12
 
 
At the same time, it is evident that PD is associated with some degree of operational deficit in 
driving ability, even if there is currently limited evidence that safety is compromised. Awareness 
of this in assessors may help the development of targeted interventions to tackle these deficits, 
improving competency when more challenging driving situations are encountered. PD deficits may 
be similar to those of the older driver, and may benefit from specific areas of retraining 
highlighted by assessment, such as awareness of road positioning and speed regulation.
17
 
 
Limitations of the study should be noted. First, real-life crash data was based on self-report, and 
fear of licence revocation or encouraging negative perceptions may cause drivers with PD to 
under-report their crash involvement.
6
  Inaccuracy of reporting may be also a product of a 
diminished higher-order ability to self-reflect on performance deficits exhibited by some PD 
patients,
15
 and efforts to develop accurate assessment of such metacognitive deficits may also be 
an important factor in determining driving capacity. Interestingly, crash statistics from the one 
primary study that used state records
5,25
 were only negligibly different from overall meta-analytic 
summary estimates that were otherwise based on self-report. Furthermore, a recent study found 
‘substantial’ agreement between self-reported and state-recorded crashes in 2000 older adults
18
 
who may be susceptible to similar bias. Nevertheless, it would be unwise to draw firm conclusions 
without further corroborating evidence. Second, PD study samples in OTR and simulator studies 
may be biased towards more confident drivers less fearful of evaluation,
6
 which would suggest 
driving ability might even be further impaired in the wider PD population. Third, while we found 
no evidence that the lack of inflated real-life crash risk in PD might be due to reduced driving 
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exposure, limited available information and the variety of different metrics used (e.g. trips, 
monthly mileage) restricted analytical power of our analysis and it is unwise to discount this as a 
possible explanatory factor. Similarly, factors such as daytime sleepiness/sudden sleep onset, non-
use of medication, visuospatial deficits and severe global cognitive impairment (beyond the level 
commonly specified by study entry criteria), may also contribute to driving impairment but could 
not but be examined due to inadequate data for meta-analysis.  Fourth, while meta-analytic 
summary data provides important information on ‘average’ impairment,  PD is a heterogeneous 
condition and thorough assessment of each individual case is essential to reliably determine 
fitness to drive. 
 
Further research examining real-life driving based on large-sample ‘objective’ crash statistics such 
as transport department records and insurance data, or empirical naturalistic driving data such as 
computerized multimodal quantitative assessments of driver behaviour in the driver’s own 
vehicle,
29
 are needed to corroborate self-report findings. Although such databases are not 
currently readily accessible, future availability would increase confidence in the current findings 
and potentially highlight in what situations crash vulnerability might be increased. Insights into 
whether overall driving impairment is primarily driven by selective impairment in individual 
motor, cognitive or visual deficits or for specific driving situations would also be gained by large 
sample OTR and simulator studies with carefully specified a priori comparison of outcomes. Such 
research could help target areas of driving impairment for retraining. 
 
Meta-analysis of a total of 5,410 participants across 50 studies found persuasive evidence of 
driving performance deficits in those with PD. Participants with PD had an odds of on-the- test 
failure more than 6 times higher than controls, had more crashes in driving simulators and were 
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rated more poorly on overall driving performance. However, there is currently no evidence of an 
increased crash risk in real life driving based on self-report data, although corroborative objective 
indices are required. Driving is an important public safety issue and ensuring fitness to drive is 
paramount to minimising injuries and fatalities that occur on the road. However, these results do 
little to support mandated periodic driving reassessment for Parkinson’s patients based on 
currently available evidence, and encourage thorough individualized assessment as the most 
appropriate method for determining fitness to drive. 
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Table e-1. Study characteristics 
Study N PD Severity
a
 
(duration, 
severity scores) 
PD Usual 
medication
b
 
Driving 
Model 
Outcome 
Jitkritsadakul 
2017
22
 
41 (PD)  
41 (HC) 
9 yrs, 
HY=2.5 
NR Real-life 
Simulator  
Crashes in last year 
Reaction time (e.g. to falling object), driving ‘mistakes’ 
Uc et al 2017
45
 67 (PD)  
110 (HC) 
6.9 yrs, 
UPDRS-3=24, 
HY=2.2 
NR  (DA+other 67%) Real-life 
On-road 
Crash rate in preceding year 
Errors (speed regulation, lane changing, overtaking, 
parking, rail road crossing, stop signs, signals etc.) 
Jitkritsadakul 
2016
23
 
60 (PD)  
60 (HC) 
 NR Real-life 
Simulator  
Crash rate in preceding year 
Reaction time (e.g. to falling object), driving ‘mistakes’ 
Pavlou, Beratis 
et al 2016
31
 
25 (PD)  
31 (HC) 
 NR Simulator Speed variability, headway, lane deviation, reaction 
time 
Pavlou et al 
2016
30
 
25 (PD)  
31 (HC) 
 NR Simulator Crash rate, Reaction time 
Ranchet et al 
2016
32
 
16 (PD)  
21 (HC) 
6.9 yrs, 
UPDRS-3=17, 
HY=2.2 
LD+DA+MAO (89%), 
MAO (5%), DA (5%) 
Simulator Speed variability 
Vardaki et al 
2016
46
 
10 (PD)  
10 (HC) 
UPDRS-3=12.9, 
HY=1.9 
NR Real-life 
Simulator  
Crashes in last 2 yrs 
Speed 
Aksan et al 
2015
2
 
39 (PD)  
77 (HC) 
 NR On-road 7 error types (lane change, lane observance, speed 
control, traffic signs, stop signs, turns, pulling off from 
curb) 
Chen et al 2015
7
 16 (PD)  
18 (HC) 
UPDRS-3=12.4, 
HY=1.8 
NR Simulator Speed regulation, lane deviation, gap acceptance 
Dotzauer et al 
2015
16
 
9 (PD) 
9 (HC) 
5.7 yrs NR Simulator Speed regulation, headway 
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Buhmann et al 
2014
4
 
21 (PD)  
21 (HC) 
6 yrs, HY=1.9  *LD (57%), DA 
(76%), MAO-B 
(42%), COMT (23%), 
amandatine (33%), 
anticholinergics 
(10%) 
Simulator Driving test errors 
Classen et al 
2014
8
 
101 (PD)  
138 (HC) 
UPDRS-3=25.9, 
HY=2 (median) 
NR Real-life 
On-road 
Crashes (rate and mean number) in last 3 yrs 
Driving test result (pass/fail) 
8 error categories (vehicle positioning, speed 
regulation, lane maintenance, yielding, signalling, 
visual scanning, adjustment to environment, gap 
acceptance)  
Papadimitriou 
2014
29
 
7 (PD)  
17 (HC) 
 NR Simulator Speed variability, headway, lane deviation 
Crizzle et al 
2013
14
 
27 (PD)  
20 (HC) 
3.9 yrs, 
UPDRS-3=30.1 
LD (85%), rasagiline 
(7%), ropinirole 
(4%), rasagiline + 
ropinirole (4%) 
Real-life Reaction time 
Crizzle and 
Myers 2013
13
 
27 (PD)  
20 (HC) 
3.9 yrs, UPDRS-
3=30.1 
LD (85%), rasagiline 
(7%), ropinirole 
(4%), rasagiline + 
ropinirole (4%) 
Real-life Speed 
Chee et al 2013
5
 28 (PD)  
30 (HC) 
HY=1.7 NR Simulator Performance scores (speed regulation, stop signs, 
lane deviation, road edge excursions, stop at lights) 
Crashes 
Dotzauer et al 
2013
17
 
9 (PD) 
9 (HC) 
5.7 yrs NR Simulator Crash rate 
 
Ranchet et al 
2013
33
 
19 (PD)  
21 (HC) 
7.5 yrs,  
UPDRS-3=16.4, 
HY=2.1 
LD + DA + MAO 
(89%), MAO (5%), 
DA (5%) 
On-road Errors (lateral position control, following distance, 
speed regulation, visual information processing, 
traffic signals, overtaking behavior, traffic insight, 
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interaction with traffic) 
Instructor interventions 
Crizzle et al 
2012
12
 
20 (PD)  
148 (HC) 
 NR On-road Driving test result (pass/fail) 
Classen et al 
2011
10
 
41 (PD)  
41 (HC) 
UPDRS-3=27.4, 
HY=2.4 
NR On-road Driving test result (pass/fail) 
8 error categories from 91 manoeuvres (e.g. vehicle 
positioning, speed regulation, lane maintenance, 
yielding, signalling, visual scanning, adjustment to 
environment, gap acceptance) 
Lee et al 2011
25
 53 (PD)  
129 (HC) 
5.3 yrs,  
UPDRS-3=18, 
HY=1.6 
LD (NR%) Simulator Performance score (lane changing, traffic signs, T-
junctions, speed regulation), Crashes 
Scally 2011
34
 19 (PD)  
19 (HC) 
6.6 yrs,  
UPDRS-3=15.4 
LD (47%), LD + DA 
(26%), LD + COMT 
(26%) 
Simulator Reaction time (approaching red light) 
Uc et al 2011
41
 106 (PD)  
130 (HC) 
5.9 yrs,  
UPDRS-3=24.9, 
HY=2.2 
NR Real-life 
On-road 
(Prospective) crash rate in two year follow-up period 
Driving test errors (e.g. starting, pulling away from 
curb, traffic signals and signs, turns, lane 
observations, overtaking , speed, regulation, reverse 
driving, parking manoeuvres etc.) 
Barrash et al 
2010
3
 
33 (PD)  
24 (HC) 
HY=3 NR On-road 76 error types (e.g. starting, pulling away from curb, 
traffic signals and signs, turns, lane observations, 
overtaking another vehicle, control of speed, reverse 
driving, parking manoeuvres) 
Chee et al 2010
6
 7 (PD)  
15 (HC) 
HY=1.6 NR Simulator Performance scores (speed regulation, stop signs, 
lane deviation, road edge excursions, stop at lights) 
Crashes 
Vaux et al 
2010
47
 
8 (PD)  
18 (HC) 
 NR Real-life 
Simulator 
Crashes in last 2 yrs 
Collision detection score 
Uc et al 2009
40
 67 (PD)  6.5 yrs, UPDRS- NR Simulator Lane deviation, reaction time (to crash), Crash rate 
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51 (HC) 3=25.6, HY=2.3 
Uc et al 2009
37
 84 (PD)  
182 (HC) 
5.9 yrs,  
UPDRS-3=25.6, 
HY=2.2 
NR On-road Errors (lane changing, steering, speed regulation etc.) 
Classen et al 
2009
9
 
19 (PD)  
104 (HC) 
4.9 yrs,  
UPDRS-3=25.6 
NR On-road Driving test result (pass/fail) 
8 error categories (vehicle positioning, speed 
regulation, lane maintenance, yielding, signalling, 
visual scanning, adjustment to environment, gap 
acceptance) 
Cordell et al 
2008
11
 
53 (PD)  
129 (HC) 
5.3 yrs,  
UPDRS-3=18, 
HY=1.6 
NR On-road Performance scores (traffic signs, roundabouts, 
steering, braking, traffic lights, indicators) 
Devos et al 
2007
15
 
40 (PD)  
40 (HC) 
6.7 yrs,  
UPDRS-3=20.4, 
HY=2 (median) 
NR Simulator 13 Performance items (e.g. speed regulation, traffic 
light faults) 
Kaußner et al 
2007
24
 
24 (PD)  
24 (HC) 
6.7 yrs,  
UPDRS-3=18.5 
LD + DA (79%), DA 
(21%) 
Real-life 
Simulator 
Crash rate in preceding 5 years 
Lane deviation, speed regulation 
McCarthy et al 
2007
28
 
19 (PD)  
62 (HC) 
UPDRS-3=25.9 NR On-road Driving test result (pass/fail) 
Errors (lane deviation, speed variability)  
Uc et al 2007
43
 77 (PD)  
152 (HC) 
5.7 yrs,  
UPDRS-3=23.7, 
HY=2.2 
LD + DA (36%), LD 
(27%), DA (29%), 
other (7%) 
On-road Errors (e.g. steering, lane deviation, shoulder 
incursion, stopping/slowing in unsafe circumstances, 
unsafe intersection behavior) 
Uc et al 2006
44
 31 (PD)  
19 (HC) 
 NR Simulator Errors (e.g. steering, lane deviation, shoulder 
incursion, stopping/slowing in unsafe circumstances, 
unsafe intersection behavior) 
Uc et al 2006
42
 71 (PD)  
147 (HC) 
5.3 yrs,  
UPDRS-3=23.5, 
HY=2.1 
LD + DA (36%), LD 
(27%), DA (29%), 
other (7%) 
On-road Errors (e.g. steering, lane deviation, shoulder 
incursion, stopping/slowing in unsafe circumstances, 
unsafe intersection behavior) 
Uc et al 2006
39
 79 (PD)  
151 (HC) 
5.6 yrs,  
UPDRS-3=24.1, 
LD + DA (36%), LD 
(27%), DA (29%), 
On-road Errors (e.g. steering, lane deviation, shoulder 
incursion, stopping/slowing in unsafe circumstances, 
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HY=2.2 other (7%) unsafe intersection behavior) 
Uc et al 2006
38
 71 (PD)  
147 (HC) 
HY=3 LD + DA (36%), LD 
(27%), DA (29%), 
other (7%) 
On-road Errors (e.g. steering, lane deviation, shoulder 
incursion, stopping/slowing in unsafe circumstances, 
unsafe intersection behavior) 
Ferreira et al 
2006
19
 
176 (PD)  
174 (HC) 
10 yrs,  
UPDRS-3=19.8, 
HY=2.3 
*LD (87%), DA 
(69%) 
Real-life Crashes in last 3 yrs 
Stolwyk 2006
36
 18 (PD)  
18 (HC) 
6.7 yrs,  
UPDRS-3=11.7 
LD + other (95%), 
other (5%) 
Simulator Speed approaching red light, speed variability, lane 
deviation 
Worringham et 
al 2006
49
 
25 (PD)  
21 (HC) 
6.2 yrs,  
UPDRS-3=27.4, 
HY=2.3 
NR On-road Driving test result (pass/fail) 
Grace et al 
2005
20
 
21 (PD)  
21 (HC) 
7.1 yrs,  
UPDRS-3=28.4, 
HY=2 (mode) 
LD + DA (38%), LD 
(29%), DA (29%) 
Real-life 
On-road 
Crash rate in preceding 3 years 
Driving test result (safe/unsafe) 
Errors (e.g. lane changing, signalling, speed 
regulation) 
Stolwyk et al 
2005
35
 
18 (PD)  
18 (HC) 
6.7 yrs,  
UPDRS-3=11.7 
LD + other (95%), 
other (5%) 
Simulator Reaction time approaching red light, speed variability, 
lane deviation 
Wood et al 
2005
48
 
25 (PD)  
21 (HC) 
6.2 yrs,  
UPDRS-3=27.4, 
HY=2.3 
NR Real-life 
On-road 
Crash rate in preceding 10 years 
Instructor interventions 
Errors (e.g. lane deviation, braking, indicating, gap 
selection approach, blind spot) 
Zesiewicz et al 
2002
50
 
39 (PD)  
25 (HC) 
UPDRS-3=17.8, 
HY=2.2 
NR Simulator Crashes (rate and mean number) 
Adler et al 
2000
1
 
89 (PD)  
423 (HC) 
5.8 yrs NR Real-life Crash rate in preceding 3 years 
Heikkila 1998
21
 20 (PD)  
20 (HC) 
5.6 yrs,  
HY=1.9 
LD + MAO (65%), LD 
+ MAO + DA (30%), 
LD + MAO + COMT 
(5%) 
On-road Driving test result (pass/fail) 
Errors (a broad range from Finnish driving test) 
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Lings et al 
1992
26
 
28 (PD)  
109 (HC) 
8.8 yrs, HY=2.2 *LD (89%),  
anticholinergic 
(37%), DA (29%) 
Simulator Reaction time (traffic lights) 
Dubinsky 1991
18
 45 (PD)  
100 (HC) 
10.5 yrs, HY=3 NR Real-life Crashes in last 3 yrs 
Madeley et al 
1990
27
 
10 (PD)  
10 (HC) 
HY=1.9 NR Simulator Steering errors, reaction time, red lights missed 
a
PD Severity: UPDRS-3=Unified Parkinson’s Disease Rating Scale-3 (motor subscale), HY=Hoehn and Yahr scale, 
b
PD Medication: LD=Levodopa, DA=Dopamine agonist, MAO=Monoamine Oxidase inhibitor, COMT=Catechol-O-methyltransferase inhibitor. 
*includes use of medication alone and in combination with other PD medications.  
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For more information, visit www.prisma-statement.org. 
 
Figure 1. PRISMA 2009 Flow Diagram 
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Additional records identified 
through other sources 
(n = 7) 
Records after duplicates removed 
(n = 3962) 
Records screened 
(n = 3962) 
Records excluded 
(n = 3743) 
Full-text articles assessed 
for eligibility 
(n =  226) 
Full-text articles excluded, with 
reasons (n = 172) 
No eligible control group (n=51) 
Review paper, editorial or letter (n=35) 
Duplicate data (n=27) 
No driving performance assessment (n=22) 
No PD group (n=19) 
Study of neurological disorder without 
separate PD analysis (n=8) 
No PD and no driving assessment (n=6) 
Reliability study of PD and driving (n=2) 
Ineligible driving model (n=1) 
Secondary Parkinsonism only (n=1) 
Studies included in 
qualitative synthesis 
(n = 54) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 50) 
Excluded - missing data 
(n = 4) 




